NCT05558813Withdrawn
Natural History of Duchenne Muscular Dystrophy Cardiomyopathy (DMD-CMP)
Prospective Cardiac Magnetic Resonance Imaging Study in Duchenne Muscular Dystrophy (DMD-CMP)
Source: ClinicalTrials.gov · Last updated 20 Nov 2025
Reason given: Cancellation of financing by the financier.
Brief summary (registry, in English)
The purpose of this study is to describe the progression of tissular and functional myocardial abnormalities in patients with Duchenne muscular dystrophy using cardiac magnetic resonance imaging and blood biomarkers assays.
- Status (registry)
- Withdrawn
- Study type
- Interventional
- Enrollment
- 0 (actual)
- First submitted
- 15 Apr 2022
- Start date
- Nov 2024
- Primary completion date
- Feb 2029
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Diseases
- Duchenne muscular dystrophy
- NCT number
- NCT05558813
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Tracheostomy of hospitalisation for acute respiratory failure <1 year
- Contraindication to MRI: claustrophobia, Gadolinum allergy
Lab values
- Left ventricular ejection fraction <30%
Age
- Age <6 years
Who the study is looking for
- Age >= 6 years
- Genetically proven Duchenne muscular dystrophy
- Affiliation to French medical insurance
- Informed consent provided
Age in the registry: 6 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Necker Hospital | Paris | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.